Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Santen Pharmaceutical CO Ltd (SNPHF)

Santen Pharmaceutical CO Ltd (SNPHF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.21
Trade SNPHF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.6000 unch
on 03/03/21
16.2500 -16.31%
on 02/09/21
-3.0500 (-18.32%)
since 02/02/21
3-Month
13.6000 unch
on 03/03/21
16.8000 -19.05%
on 02/01/21
-2.6500 (-16.31%)
since 12/02/20
52-Week
13.6000 unch
on 03/03/21
20.1500 -32.51%
on 10/09/20
-2.5000 (-15.53%)
since 03/02/20

Most Recent Stories

More News
Verkazia™ for the Treatment of Severe Vernal Keratoconjunctivitis is now Publicly Reimbursed in Quebec

Verkazia™ for the Treatment of Severe Vernal Keratoconjunctivitis is now Publicly Reimbursed in Quebec

SNPHF : 13.6000 (-3.55%)
Nystagmus Market 2023: Size, Share, Growth, Trends, Demand, Industry Analysis, Regional Outlook

AERI : 18.75 (-2.60%)
AGN : 193.02 (+0.02%)
BAYRY : 15.4550 (+0.10%)
BMY : 60.43 (+1.84%)
NVS : 84.01 (+0.61%)
PFE : 34.39 (+0.56%)
REGN : 461.57 (+2.71%)
SNPHF : 13.6000 (-3.55%)
VRX.TO : 30.80 (-3.33%)
Ophthalmology Drugs and Devices Market Size, Share to expand at 6.16% CAGR through 2027 - Industry News

Selbyville, Delaware. The report Ophthalmology Drugs and Devices Market Size and Analysis maintains enhanced dynamics and is overshadowed by a top player across the globe. The research report provides...

AGN : 193.02 (+0.02%)
GSK : 34.91 (+1.84%)
RHHBY : 40.5900 (+0.22%)
SNPHF : 13.6000 (-3.55%)
VRX.TO : 30.80 (-3.33%)
Anophthalmia And Microphthalmia Market Size Is Expected to Exhibit 5.8% CAGR By 2023

AERI : 18.75 (-2.60%)
AGN : 193.02 (+0.02%)
BAYRY : 15.4550 (+0.10%)
NVS : 84.01 (+0.61%)
PFE : 34.39 (+0.56%)
REGN : 461.57 (+2.71%)
SNPHF : 13.6000 (-3.55%)
VRX.TO : 30.80 (-3.33%)
Glaucoma Therapeutics Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027

The Global is estimated to value over USD 10.1 billion by 2027 end with a CAGR of over 6% during the forecast period 2020 to 2027.

AERI : 18.75 (-2.60%)
AGN : 193.02 (+0.02%)
ITEK : 3.04 (-5.00%)
NVS : 84.01 (+0.61%)
PFE : 34.39 (+0.56%)
SNPHF : 13.6000 (-3.55%)
TEVA : 10.52 (-0.57%)
VRX.TO : 30.80 (-3.33%)
Glaucoma Drugs Market Size | Global Industry Analysis and Opportunity Assessment 2021-2027

The latest research report on delivers a comprehensive study on current market trends. The outcome also includes revenue forecasts, statistics, market valuations which illustrate its growth trends and...

AERI : 18.75 (-2.60%)
AGN : 193.02 (+0.02%)
ITEK : 3.04 (-5.00%)
MRK : 73.13 (+1.33%)
NMUS : 0.6500 (-9.52%)
NVS : 84.01 (+0.61%)
OCAT : 8.47 (+0.12%)
OCUL : 18.51 (+6.81%)
OHRP : 5.39 (+30.19%)
PRGO : 41.04 (+1.16%)
PFE : 34.39 (+0.56%)
SNPHF : 13.6000 (-3.55%)
SCMP : 18.05 (+0.28%)
TEVA : 10.52 (-0.57%)
VRX.TO : 30.80 (-3.33%)
Ophthalmic drugs Market Size Estimated to Surpass USD 37,700 Million By 2026, Globally: Facts & Factors

Facts and Factors have published a new research report titled "Ophthalmic Drug Market By Type (Over-the-Counter Drugs and Prescription Drugs), By Drug Class (Anti-inflammatory Drugs, Anti-Infective Drugs,...

AGN : 193.02 (+0.02%)
BAYRY : 15.4550 (+0.10%)
NVS : 84.01 (+0.61%)
PFE : 34.39 (+0.56%)
SNPHF : 13.6000 (-3.55%)
Anophthalmia And Microphthalmia Market Size Is Projected to grow at a 5.8% CAGR By 2023

AERI : 18.75 (-2.60%)
AGN : 193.02 (+0.02%)
BAYRY : 15.4550 (+0.10%)
NVS : 84.01 (+0.61%)
PFE : 34.39 (+0.56%)
REGN : 461.57 (+2.71%)
SNPHF : 13.6000 (-3.55%)
VRX.TO : 30.80 (-3.33%)
US Glaucoma Drugs Market Size 2021 By Trends Evaluation, Business Opportunities, Consumption, Growth Rate, Top Manufacturer, New Project Investment, Regional Analysis and Forecast to 2027

AI Market Report is working on a new report title Global Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2027? Rise in prevalence of eye disorders such as Presbyopia, Macular Degeneration...

AGN : 193.02 (+0.02%)
ITEK : 3.04 (-5.00%)
MRK : 73.13 (+1.33%)
NMUS : 0.6500 (-9.52%)
NVS : 84.01 (+0.61%)
OCAT : 8.47 (+0.12%)
OCUL : 18.51 (+6.81%)
OHRP : 5.39 (+30.19%)
PRGO : 41.04 (+1.16%)
PFE : 34.39 (+0.56%)
SNPHF : 13.6000 (-3.55%)
SCMP : 18.05 (+0.28%)
TEVA : 10.52 (-0.57%)
VRX.TO : 30.80 (-3.33%)
Anophthalmia And Microphthalmia Market Regional Insights, Growth Outlook, Business Overview, Share Value and Size Estimation By 2023

AERI : 18.75 (-2.60%)
AGN : 193.02 (+0.02%)
BAYRY : 15.4550 (+0.10%)
NVS : 84.01 (+0.61%)
PFE : 34.39 (+0.56%)
REGN : 461.57 (+2.71%)
SNPHF : 13.6000 (-3.55%)
VRX.TO : 30.80 (-3.33%)

Key Turning Points

3rd Resistance Point 13.6000
2nd Resistance Point 13.6000
1st Resistance Point 13.6000
Last Price 13.6000
1st Support Level 13.6000
2nd Support Level 13.6000
3rd Support Level 13.6000

See More

52-Week High 20.1500
Fibonacci 61.8% 17.6479
Fibonacci 50% 16.8750
Fibonacci 38.2% 16.1021
Last Price 13.6000
52-Week Low 13.6000

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar